eHealth (NASDAQ:EHTH - Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, November 6th. Analysts expect the company to announce earnings of ($1.30) per share for the quarter. eHealth has set its FY 2024 guidance at EPS.Investors interested in listening to the company's conference call can do so using this link.
eHealth (NASDAQ:EHTH - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The financial services provider reported ($1.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.85) by ($0.38). The firm had revenue of $65.86 million for the quarter, compared to analyst estimates of $55.79 million. eHealth had a negative net margin of 6.32% and a negative return on equity of 4.03%. On average, analysts expect eHealth to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
eHealth Stock Performance
NASDAQ:EHTH traded up $0.01 on Wednesday, hitting $5.01. 34,418 shares of the stock were exchanged, compared to its average volume of 256,914. eHealth has a 52 week low of $3.58 and a 52 week high of $9.45. The stock has a market capitalization of $147.32 million, a price-to-earnings ratio of -1.85 and a beta of 0.53. The company's 50-day moving average price is $4.24 and its 200 day moving average price is $4.62.
Analysts Set New Price Targets
A number of analysts have commented on the stock. Craig Hallum lowered their target price on shares of eHealth from $6.00 to $5.00 and set a "hold" rating for the company in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft cut their target price on eHealth from $5.00 to $2.00 and set a "hold" rating on the stock in a research note on Wednesday, August 14th. Finally, StockNews.com downgraded shares of eHealth from a "hold" rating to a "sell" rating in a research report on Monday.
Check Out Our Latest Stock Report on EHTH
Insider Activity
In related news, SVP Gavin G. Galimi bought 10,365 shares of the company's stock in a transaction on Thursday, August 8th. The shares were purchased at an average cost of $4.12 per share, for a total transaction of $42,703.80. Following the acquisition, the senior vice president now owns 185,290 shares of the company's stock, valued at approximately $763,394.80. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. In other news, SVP Gavin G. Galimi purchased 10,365 shares of eHealth stock in a transaction on Thursday, August 8th. The stock was purchased at an average price of $4.12 per share, with a total value of $42,703.80. Following the transaction, the senior vice president now directly owns 185,290 shares in the company, valued at $763,394.80. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO John J. Stelben acquired 20,000 shares of the stock in a transaction dated Thursday, August 8th. The stock was acquired at an average price of $4.16 per share, for a total transaction of $83,200.00. Following the completion of the acquisition, the chief financial officer now directly owns 515,565 shares of the company's stock, valued at $2,144,750.40. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 80,365 shares of company stock worth $329,404 in the last 90 days. Corporate insiders own 4.10% of the company's stock.
eHealth Company Profile
(
Get Free Report)
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
Featured Stories
Before you consider eHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eHealth wasn't on the list.
While eHealth currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.